Determinants of successful ablation and complete remission after total thyroidectomy and 131I therapy of paediatric differentiated thyroid cancer

被引:0
|
作者
Frederik A. Verburg
Uwe Mäder
Markus Luster
Heribert Hänscheid
Christoph Reiners
机构
[1] University of Würzburg,Department of Nuclear Medicine
[2] University of Würzburg,Comprehensive Cancer Center Mainfranken
[3] RWTH University Hospital Aachen,Department of Nuclear Medicine
[4] University Hospital Giessen and Marburg,Department of Nuclear Medicine
关键词
Differentiated thyroid carcinoma; Complete remission; I Therapy; Paediatric cancer; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1390 / 1398
页数:8
相关论文
共 50 条
  • [41] Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer
    Van Nostrand, D.
    ORAL DISEASES, 2011, 17 (02) : 154 - 161
  • [42] Successful pregnancy after radiotherapy with 131I for differentiated thyroid cancer. A case report and review of the literature
    Grammatikakis, I.
    Trakakis, E.
    Evangelinakis, N.
    Hintipas, E.
    Salamalekis, G.
    Kassanos, D.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2010, 37 (04): : 328 - 330
  • [43] 131I Ablation of an Entire Thyroid Gland in Locally Invasive Differentiated Thyroid Cancer Without Surgery
    Yung, Grace
    Forwood, Nicholas
    Russo, Robert
    Ganda, Kirtan
    Mansberg, Robert
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (11) : 915 - 918
  • [44] Predictive value of the preablation serum thyroglobulin level after thyroidectomy is combined with postablation 131I whole body scintigraphy for successful ablation in patients with differentiated thyroid carcinoma
    Lee, Hyo Jin
    Rha, So Young
    Jo, Young Suk
    Kim, Seong Min
    Ku, Bon Jeong
    Shong, Minho
    Kim, Young Kun
    Ro, Heung Kyu
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2007, 30 (01): : 63 - 68
  • [45] Postablative 131I SPECT/CT Is Much More Sensitive Than Cervical Ultrasonography for the Detection of Thyroid Remnants in Patients After Total Thyroidectomy for Differentiated Thyroid Cancer
    Bulzacka, Iwona
    Makarewicz, Jacek
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (12) : 948 - 953
  • [46] The clinical usefulness of 131I scans on tenth day after 131I therapy in patients with well-differentiated thyroid cancer: comparison with third day 131I scans
    Lee, J.
    Lee, S.
    Koh, G.
    Lee, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S345 - S346
  • [47] Advantages of dosimetry in 131I therapy of differentiated thyroid carcinoma
    Verburg, Frederik A.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 63 (03): : 253 - 257
  • [48] Only a Rapid Complete Biochemical Remission After 131 I-Therapy is Associated with an Unimpaired Life Expectancy in Differentiated Thyroid Cancer
    Verburg, Frederik A.
    Maeder, Uwe
    Grelle, Inge
    Giovanella, Luca
    Reiners, Christoph
    Haenscheid, Heribert
    HORMONE AND METABOLIC RESEARCH, 2017, 49 (11) : 860 - 868
  • [49] Outcome of different activity of 131I for first remnant ablation in the patients with differentiated thyroid cancer
    Chen, Yonghui
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [50] Review:: 131I activity for remnant ablation in patients with differentiated thyroid cancer:: A systematic review
    Hackshaw, Allan
    Harmer, Clive
    Mallick, Ujjal
    Haq, Masud
    Franklyn, Jayne A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 28 - 38